Geneos Wealth Management’s Goldman Sachs ActiveBeta US Large Cap Equity ETF GSLC Stock Holding History
Bought
Maintained
Sold
Other funds holding GSLC
Geneos Wealth Management's GSLC Position: Q3 2026 in Review
Geneos Wealth Management reduced its Goldman Sachs ActiveBeta US Large Cap Equity ETF (GSLC) stake by 7.5% in Q3 2026, selling an estimated $3.33K and leaving 285 shares worth $41.3K. The position accounts for ﹤0.01% of the portfolio, ranked #1771.
Geneos Wealth Management first reported a position in GSLC in Q1 2018 and has held it in 30 quarters since. The position peaked at $161K in Q1 2018. 659 funds tracked by Wall St. Rank hold GSLC as of Q3 2026.
- Geneos Wealth Management held 285 shares of Goldman Sachs ActiveBeta US Large Cap Equity ETF worth $41.3K as of Q3 2026.
- Geneos Wealth Management sold 23 Goldman Sachs ActiveBeta US Large Cap Equity ETF shares in Q3 2026, an estimated $3.33K.
- Goldman Sachs ActiveBeta US Large Cap Equity ETF made up ﹤0.01% of Geneos Wealth Management's portfolio in Q3 2026, its #1771 holding.
- Geneos Wealth Management first reported a position in Goldman Sachs ActiveBeta US Large Cap Equity ETF in Q1 2018 and has held it in 30 quarters since.
- Geneos Wealth Management's Goldman Sachs ActiveBeta US Large Cap Equity ETF position peaked at $161K in Q1 2018.
- 659 funds tracked by Wall St. Rank held Goldman Sachs ActiveBeta US Large Cap Equity ETF as of Q3 2026.
Based on Geneos Wealth Management's 13F filing for Q3 2026, filed 9 Nov 2026.